Company Profile

ANP Technologies Inc
Profile last edited on: 4/4/2022      CAGE: 3AVW6      UEI: PNL1U1FNPLF9

Business Identifier: Biodefense and nano-therapeutics and nano-diagnostic tests.
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

824 Interchange Boulevard
Newark, DE 19711
   (302) 283-1730
Location: Single
Congr. District: 00
County: New Castle

Public Profile

Originally spun out from the US Army Research Laboratory and having now more than two decades of experience, ANP Technologies, Inc. is a nanobiotechnology company focused primarily on design, development, and marketing of innovative technologies: cutting-edge technology platforms addressing: Specialty CRO for biological drug R&D; Biodefense and homeland security; Home/point-of-care diagnostic systems and Nanoencapsulation and targeted drug delivery and therapy. ANP has been a provider of rapid, multiplexed lateral flow tests for the detection of various biological agents for DOD several years and has successfully licensing various pre-clinical and clinical stage nanotherapeutics to companies such as Celgene/BMS and Fulgent Pharma. Additionally, more recently ANP has developed COVID-19 antigen and neutralizing antibody rapid tests

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Ray Yin -- Founder, President and Chief Technology Officer

  Robert Daniel

  Ryen Hydutsky

  Matthew Odom

  Yli Remo Vallejo -- Director of Product Development

  Greg Witham -- Senior Director, Business Development & Contracts